HomeCompareEMBCV vs MO

EMBCV vs MO: Dividend Comparison 2026

EMBCV yields 6.00% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $48.0K in total portfolio value· pulled ahead in Year 6
10 years
EMBCV
EMBCV
● Live price
6.00%
Share price
$33.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.7K
Annual income
$879.62
Full EMBCV calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — EMBCV vs MO

📍 MO pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMBCVMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMBCV + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMBCV pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMBCV
Annual income on $10K today (after 15% tax)
$510.05/yr
After 10yr DRIP, annual income (after tax)
$747.68/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $23,875.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMBCV + MO for your $10,000?

EMBCV: 50%MO: 50%
100% MO50/50100% EMBCV
Portfolio after 10yr
$53.7K
Annual income
$14,924.08/yr
Blended yield
27.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

EMBCV
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$36.00
+8.0% upside vs current
Range: $36.00 — $36.00
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMBCV buys
0
MO buys
0
No recent congressional trades found for EMBCV or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMBCVMO
Forward yield6.00%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$29.7K$77.7K
Annual income after 10y$879.62$28,968.54
Total dividends collected$7.4K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$36.00$61.25

Year-by-year: EMBCV vs MO ($10,000, DRIP)

YearEMBCV PortfolioEMBCV Income/yrMO PortfolioMO Income/yrGap
1$11,300$600.06$10,558$768.31+$742.00EMBCV
2$12,725$633.71$11,352$1,015.87+$1.4KEMBCV
3$14,282$666.93$12,482$1,367.86+$1.8KEMBCV
4$15,982$699.59$14,103$1,883.39+$1.9KEMBCV
5$17,832$731.62$16,472$2,664.91+$1.4KEMBCV
6← crossover$19,843$762.92$20,024$3,897.79$181.00MO
7$22,026$793.43$25,537$5,933.74$3.5KMO
8$24,391$823.07$34,478$9,476.77$10.1KMO
9$26,950$851.82$49,776$16,022.63$22.8KMO
10$29,716$879.62$77,699$28,968.54$48.0KMO

EMBCV vs MO: Complete Analysis 2026

EMBCVStock

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Full EMBCV Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this EMBCV vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMBCV vs SCHDEMBCV vs JEPIEMBCV vs OEMBCV vs KOEMBCV vs MAINEMBCV vs PMEMBCV vs BTIEMBCV vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.